Nicole Sandford's most recent trade in Aspira Women`s Health Inc was a trade of 25,000 Restricted Stock Units done . Disclosure was reported to the exchange on Oct. 28, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aspira Women`s Health Inc | Nicole Sandford | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 13,072 | 13,072 | - | - | Warrant (Right to buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 13,072 | 83,668 (0%) | 0% | - | Common Stock | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 31 May 2024 | 9,493 | 70,596 (0%) | 0% | 2.4 | 22,973 | Common Stock |
| Aspira Women`s Health Inc | Nicole Sandford | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 80,000 | 80,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 30,000 | 30,000 | - | - | Employee stock option (right to buy) | |
| Aspira Women`s Health Inc | Sandford Nicole | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.36 per share. | 06 Dec 2023 | 5,000 | 58,703 (0%) | 0% | 3.4 | 16,800 | Common Stock |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2023 | 26,367 | 187,499 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2023 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 26,467 | 161,132 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 24 Jul 2023 | 12,563 | 134,665 (0%) | 0% | 4.0 | 50,001 | Common stock |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 500,000 | 500,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 250,000 | 250,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2023 | 2,400 | 2,400 | - | - | Warrant (Right to Buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2023 | 2,400 | 61,103 (0%) | 0% | - | Common Stock | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 5,000 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION(RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 5,000 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2022 | 66,667 | 122,102 (0%) | 0% | - | Common Stock | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2022 | 66,667 | 66,667 | - | - | Warrant (Right to buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.76 per share. | 16 May 2022 | 98,000 | 136,160 (0%) | 0% | 0.8 | 74,892 | Common Stock |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 5,000 | 5,000 | - | - | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 5,000 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 23,033 | 55,435 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | Nicole Sandford | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 5,000 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | Nicole Sandford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 15,902 | 32,402 (0%) | 0% | 0 | Common Stock |